Alvograstim

Alvograstim Caution For Usage

filgrastim

Manufacturer:

MR Pharma

Distributor:

Maxxcare

Marketer:

Mega Lifesciences
Full Prescribing Info
Caution For Usage
Special precautions for disposal and other handling: If required, Alvograstim may be diluted in glucose 50 mg/ml (5%) glucose solution for infusion.
Dilution to a final concentration less than 0.2 MU (2 micrograms) per ml is not recommended at any time.
The solution should be visually inspected prior to use. Only clear solutions without particles should be used.
For patients treated with filgrastim diluted to concentrations below 1.5 MUI (15 micrograms) per ml, human serum albumin (HSA) should be added to a final concentration of 2 mg/ml.
Example: In a final injection volume of 20 ml, total doses of filgrastim less than 30 MUI (300 micrograms) should be given with 0.2 ml of 20% human albumin solution added.
When diluted in glucose 50 mg/ml (5%) solution for infusion, filgrastim is compatible with glass and a variety of plastics including polyvinyl chloride (PVC), polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Alvograstim syringes are for single use only. Any unused product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: Alvograstim should not be diluted with saline solutions.
Diluted filgrastim may be adsorbed to glass and plastic materials.
This medicinal product must not be mixed with other products except those mentioned in above text.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in